Jazz Pharma and Sumitomo Pharma to develop therapies for sleep disorders

Ireland-based Jazz Pharmaceuticals and Sumitomo Pharma Co. in Japan, have entered into an exclusive licensing agree...

May 5, 2022 | Thursday | News
Jazz Pharma advances recombinant crisantaspase development program

Ireland based Jazz Pharmaceuticals plc has announced that the Phase 1 study of its recombinant crisantaspase molecu...

August 8, 2019 | Thursday | News
Jazz Pharma gets U.S. FDA approval for a drug that improves wakefulness

Jazz Pharmaceuticals plc has announced that the U.S. Food and Drug Administration (FDA) approved Sunosi (solriamfetol) t...

March 22, 2019 | Friday | News
Jazz Pharma gets FDA nod for Xyrem to Treat Cataplexy and EDS

Jazz Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) accepted for priority review its supplem...

June 28, 2018 | Thursday | News
BD launches FACSJazz cell sorting system

Singapore: BD Biosciences, a segment of Becton, Dickinson and Company, launched BD FACSJazz cell sorting system. It is a...

September 4, 2012 | Tuesday | News
Jazz Pharma clocks $208 mn in Q2 2013

Singapore: Jazz Pharmaceuticals reported earnings worth $208.3 million in revenue during the second quarter of 2013, an...

August 7, 2013 | Wednesday | Company results

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls